ORA BIOMEDICAL: ACCELERATING DRUG DISCOVERY FOR GEROSCIENCE

Michael Muir, Benjamin Blue, Matt Kaeberlein, Mitchell Lee · 2024

Read ORA BIOMEDICAL: ACCELERATING DRUG DISCOVERY FOR GEROSCIENCE by Michael Muir, Benjamin Blue, Matt Kaeberlein, Mitchell Lee (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11690787.txt.

Description

Michael Muir, Benjamin Blue, Matt Kaeberlein, and Mitchell Lee published a company profile in 2024 on Ora Biomedical, a firm speeding drug discovery for aging science. Few aging interventions are ready for clinical work despite a fast-growing sector. The company, spun out of a university lab, screens natural products, drugs, mixtures, and biologics for effects on aging.

Its WormBot-AI platform joins robotics, AI, and tiny worms to test lifespan and health at high volume. A crowd-funded Million Molecule Challenge opens its data to scientists in over twenty countries through a public dashboard. The authors invite academic and industry partners for screening services across disease and mutant models.

Catalog record

CREATORMichael Muir, Benjamin Blue, Matt Kaeberlein, Mitchell Lee
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11690787

Browse the full library · About the Tower of Babel